Network origin in Joseph Zenkus first degree
Entity | Entity type | Industry | |
---|---|---|---|
Lacerta Therapeutics, Inc.
Lacerta Therapeutics, Inc. BiotechnologyHealth Technology Lacerta Therapeutics, Inc. operates as a a clinical stage gene therapy company. The firm engages in development, production, and application of AAV vectors. The company was founded by Nicholas Muzyczka, Barry Byrne, Arun Srivastava, Coy Heldermon, Sergei Zolothukin, Kenneth Warrington, Ronald Mandel, Toadd E. Golde and Edgardo Rodriguez in 2017 and is headquartered in Alachua, FL.
5
| Holding Company | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Joseph Zenkus via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | General Counsel | |
QUANTERIX CORPORATION | Medical Specialties | Corporate Officer/Principal | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
Lumithera, Inc.
Lumithera, Inc. Medical SpecialtiesHealth Technology Lumithera, Inc. manufactures medical devices. It offers treatment for age-related macular degeneration. The company was founded by Clark E. Tedford, Graham Merry, James Carroll, Luis DeTaboada and Robert Dotson in 2013 and is headquartered in Poulsbo, WA. | Medical Specialties | Director/Board Member | |
Brown University | College/University | Doctorate Degree | |
ReSearch Pharmaceutical Services LLC
ReSearch Pharmaceutical Services LLC Miscellaneous Commercial ServicesCommercial Services ReSearch Pharmaceutical Services LLC provides clinical research services to the bio-pharmaceutical industry. Its services include analytical and product development, clinical operations, data services, medical and regulatory affairs, quality and training services. The company was founded by Daniel M. Perlman in 1998 and is headquartered in Fort Washington, PA. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Aldevron LLC engages in the provision of biotechnology services. It offers plasmid DNA, antibodies, and proteins. The company was founded by Michael Chambers and John Ballantyne in 1998 and is headquartered in Fargo, ND. | Biotechnology | Director of Finance/CFO | |
Fish & Neave LLP
Fish & Neave LLP Miscellaneous Commercial ServicesCommercial Services Fish & Neave operates as a law firm. It specializes in specializes in intellectual property issues involving patents, trademarks, and copyrights. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Salem State University | College/University | Undergraduate Degree | |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Soft Gel Technologies, Inc.
Soft Gel Technologies, Inc. Medical/Nursing ServicesHealth Services Soft Gel Technologies, Inc. provides soft gelatin encapsulation capibilities to the nutrition industry. Its products include 3-TriLean, CoQsol, Posinol, Injuv, LyCoQ, PharmaFew, and WasabiSol. The company was founded in 1995 and is headquartered in Los Angeles, CA. | Medical/Nursing Services | Corporate Officer/Principal | |
Ecole Supérieure de Commerce de Reims | College/University | Graduate Degree | |
Catalent Pharma Solutions, Inc.
Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Banyan Biomarkers, Inc.
Banyan Biomarkers, Inc. Medical/Nursing ServicesHealth Services Banyan Biomarkers, Inc. engages in the commercialization of vitro diagnostic tests for the detection of brain injury and neurological diseases. It develops blood test to accurately and quickly diagnose traumatic brain injury. The company was founded by Nancy Denslow, Ronald L. Hayes, and Kevin Wang in 2002 and is headquartered in San Diego, CA. | Medical/Nursing Services | Chief Executive Officer Corporate Officer/Principal | |
Par Sterile Products LLC
Par Sterile Products LLC Pharmaceuticals: GenericHealth Technology Par Sterile Products LLC engages in the development, manufacturing, and distribution of generic pharmaceuticals. Its products include adrenalin injection, adrenalin chloride solution, aplisol, argatroban injection, brevital sodium, buprenorphine HCL injection, CIII, colistimethate for injection, USP, coly-mycin m, dantrium IV, dantrium capsules, delestrogen, dexmedetomidine HCI, injection, ethacrynate sodium for injection, USP, fluphenazine decanoate injection, USP, ketalar, pitocin, tigan, triostat, vasostrict, and zoledronic acid injection. The company was founded in 2007 and is headquartered in Chestnut Ridge, NY. | Pharmaceuticals: Generic | Director of Finance/CFO | |
Institute for Commercialization of Florida Technology
Institute for Commercialization of Florida Technology Miscellaneous Commercial ServicesCommercial Services Institute for Commercialization of Florida Technology delivers company building and company funding programs to create products and companies. Its programs include company building, funding, executive council, third party solutions and startup quest. The company was founded in 2007 and is headquartered in Boca Raton, FL. | Miscellaneous Commercial Services | Chief Executive Officer | |
Fordham University School of Law | College/University | Graduate Degree | |
The University of Nevada, Reno | College/University | Undergraduate Degree | |
Florida Technology Seed Capital Fund
Florida Technology Seed Capital Fund Investment ManagersFinance Florida Technology Seed Capital Fund (Florida Technology) is a venture capital subsidiary of Institute for Commercialization of Florida Technology founded in 2011. The firm is headquartered in Tampa, Florida. | Investment Managers | Chief Executive Officer | |
Calviri, Inc.
Calviri, Inc. BiotechnologyHealth Technology Calviri, Inc. operates as a biotech company. It focuses on diagnostics for the early detection of cancer and for vaccines to eliminate cancer. The company was founded by Stephen Albert Johnston and is headquartered in Tempe, AZ. | Biotechnology | Chief Executive Officer | |
BlueRock Therapeutics Canada ULC
BlueRock Therapeutics Canada ULC BiotechnologyHealth Technology Bluerock Therapeutics engages in development of a pluripotent stem cell-derived myocardiocytes as regenerative cell therapies for restoring electrical and contractile function in patients with myocardial infarction or chronic heart failure. The company was founded by Gordon Keller and Lorenz Studer in 2016 and is headquartered in Toronto, Canada. | Biotechnology | Chief Operating Officer | |
Deepwork Capital LLC
Deepwork Capital LLC Investment ManagersFinance Deepwork Capital LLC (Deepwork Capital) is a venture capital firm founded in 2015 by Mitchel J. Laskey, Benjamin Patz and Kathy Chiu. The firm is headquartered in Orlando, Florida. | Investment Managers | Private Equity Investor | |
Reno School of Medicine | College/University | Doctorate Degree | |
Gainesville Chamber of Commerce | Director/Board Member | ||
MONTE ROSA THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Ensoma, Inc. believes in the future of medicine and is committed to creating a new therapeutic category to tackle diseases that affect millions around the world, such as cancer and autoimmune disease, as well as inherited conditions. Ensoma is based in Boston, MA and has subsidiaries in Denmark. The company's engenious™ platform combines innovative delivery technology with the full DNA editing toolkit to address these disorders. Ensoma is supported by top-tier investors, a strategic collaboration with Takeda, and a passionate team. The company was founded by André Lieber, Hans-Peter Kiem, Kush M. Parmar, and the CEO is Emile F. Nuwaysir. | Miscellaneous Commercial Services | President | |
UF Innovate Ventures
UF Innovate Ventures Investment ManagersFinance UF Innovate Ventures (UF Innovate Ventures) is a venture capital subsidiary of University of Florida founded in 2019. The firm is headquartered in Gainesville, Florida. | Investment Managers | Private Equity Investor | |
BlueRock Therapeutics LP
BlueRock Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Part of Bayer AG, BlueRock Therapeutics LP is a clinical stage cell therapy company focused on creating cellular medicines to reverse devastating diseases. The company is based in Cambridge, MA. In late 2019, BlueRock became a wholly owned, independently operated subsidiary of Bayer AG as a cornerstone of its newly formed cell & gene therapy platform. The company's culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that they are all part of something bigger than themselves. BlueRock Therapeutics' lead clinical program, Bemdaneprocel (BRT-DA01), is in phase I clinical trials for Parkinson's disease. BlueRock Therapeutics was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer, the impact investing arm of Bayer AG. Seth Ettenberg has been the CEO of the company since 2020. | Miscellaneous Commercial Services | Chief Operating Officer | |
Genascence Corp.
Genascence Corp. BiotechnologyHealth Technology Genascence Corp. develops gene therapy products for musculoskeletal diseases. The company was founded by Dr. Annahita Keravala and Dr. Thomas W. Chalberg in 2017 and is headquartered in Palo Alto, CA. | Biotechnology | Director/Board Member |
Statistics
International
United States | 30 |
France | 2 |
Canada | 2 |
Sectoral
Health Technology | 13 |
Commercial Services | 8 |
Consumer Services | 7 |
Finance | 4 |
Health Services | 3 |
Operational
Director/Board Member | 7 |
Corporate Officer/Principal | 6 |
Chief Operating Officer | 6 |
Chief Executive Officer | 5 |
Director of Finance/CFO | 4 |
Most connected contacts
Insiders | |
---|---|
Jackson Streeter | 14 |
Min Wang | 11 |
Marc Wolff | 9 |
Amy Griffin | 2 |
Edgardo Rodriguez-Lebron | 1 |
- Stock Market
- Insiders
- Joseph Zenkus
- Company connections